PMID: 8937839Aug 1, 1996Paper

The emergent needs for basic research, education, and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on Antibiotic Resistance

Diagnostic Microbiology and Infectious Disease
R N Jones

Abstract

The American Society for Microbiology (ASM) convened a task force to study the current prevelance of antibiotic resistance and the problems associated with it. The task force produced a series of recommendations centered around three key elements: (a) education of the physician and the public; (b) encouragement of more basic research directed to the development of new antimicrobials and vaccines; and (c) the setting-up of a national surveillance system to both confirm and monitor the extent of the problem. Since the publication of this report in 1995, progress has been slow. No "consortium-style" funding has been set aside and any initiatives, such as the first steps in an education program by the ASM, are still in their planning phases. The spirit of cooperation and trust needed to deal with this problem appears to be lacking.

References

Dec 1, 1992·The Journal of Infectious Diseases·M R ReichlerR O Walton
Oct 1, 1992·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·A L PanlilioW J Martone
Jul 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P C Appelbaum
Jun 11, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R C Moellering
Feb 1, 1992·Diagnostic Microbiology and Infectious Disease·R N Jones
Dec 1, 1991·The Journal of Antimicrobial Chemotherapy·F BaqueroE Loza
Sep 16, 1991·The American Journal of Medicine·D R SchabergR P Gaynes
Jun 1, 1991·The Journal of Infectious Diseases·H M BlumbergI K Wachsmuth
Mar 1, 1989·Antimicrobial Agents and Chemotherapy·K Bush
Mar 1, 1989·Antimicrobial Agents and Chemotherapy·K Bush
Mar 1, 1989·Antimicrobial Agents and Chemotherapy·K Bush
Apr 9, 1987·The New England Journal of Medicine·R S SchwalbeP H Gilligan
Apr 1, 1995·Diagnostic Microbiology and Infectious Disease·S F RittenhouseJ A Poupard
Oct 1, 1994·Antimicrobial Agents and Chemotherapy·G L Archer, M W Climo
Jul 1, 1994·The Journal of Infectious Diseases·L A LeeR V Tauxe
Jan 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P Y BochudP Francioli
Mar 29, 1994·Proceedings of the National Academy of Sciences of the United States of America·M N Swartz
Apr 15, 1994·Science·R L BerkelmanJ M Hughes
Aug 1, 1993·Antimicrobial Agents and Chemotherapy·M Arthur, P Courvalin
Jun 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G M Eliopoulos
Apr 1, 1993·Annals of Internal Medicine·C M Kunin
Nov 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J Z Jordens, M P Slack

❮ Previous
Next ❯

Citations

Aug 3, 2001·International Journal of Food Microbiology·A K KatlaH Herikstad
Nov 19, 2003·The Journal of Hospital Infection·R MastertonG Park
Jan 5, 2002·Diagnostic Microbiology and Infectious Disease·M A PfallerUNKNOWN MYSTIC Program Study Group
Jan 5, 2002·Diagnostic Microbiology and Infectious Disease·H Goossens, UNKNOWN MYSTIC Study Group (Europe)
Jan 25, 2003·Diagnostic Microbiology and Infectious Disease·Dilip MathaiUNKNOWN India Antimicrobial Resistance Study Group
Jun 23, 1998·Diagnostic Microbiology and Infectious Disease·R N Jones, M A Pfaller
Sep 13, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R N Jones, M A Pfaller
Apr 26, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D E LowR N Jones
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·Anthony R White, UNKNOWN BSAC Working Parties on Resistance Surveillance
Apr 9, 2001·Critical Care Medicine·M H Kollef
Apr 12, 2003·Critical Care Medicine·Daniel P RaymondRobert G Sawyer
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Joseph L KutiDavid P Nicolau
Oct 2, 2002·Journal of Clinical Microbiology·M A Pfaller, D J Diekema
Jan 13, 2004·Journal of Clinical Microbiology·Diane C HalsteadYvette S McCarter
Nov 20, 2009·Harm Reduction Journal·Chidi Victor NwenekaAnibal Sosa
Oct 3, 2015·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Tomohiro YamazakiHiroyuki Yamaguchi
Jul 8, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M Kolár, T Látal
Mar 19, 2019·Tropical Medicine & International Health : TM & IH·Shamim IslamDiana Aga

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.